560 results on '"Peffault De Latour, R."'
Search Results
2. Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study
3. Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP
4. The first steps towards a diverse and inclusive EBMT: a position paper
5. P12 - Algorithme d'identification des patients atteints d'Hémoglobinurie paroxystique nocturne (HPN) à partir des données du PMSI
6. Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality
7. FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study
8. Allogreffe de cellules souches hématopoïétiques chez les patients adolescents et adultes atteints de drépanocytose
9. Case 41. Cutaneous Epstein–Barr Virus post-transplant lymphoproliferative disorder
10. Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study
11. Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT
12. L’hémoglobinurie paroxystique nocturne : une cause méconnue de thrombose ?
13. Traitement de l’aplasie médullaire idiopathique en 2015
14. L’inhibiteur oral du facteur b du complément iptacopan chez les patients (pts) atteints d’hémoglobinurie paroxystique nocturne (hpn) avec hémolyse active malgré un traitement anti-c5 : efficacité et sécurité à long terme après arrêt d’éculizumab (ecu)
15. Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
16. Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
17. Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
18. S236: RANDOMIZED MULTICENTER PHASE III STUDY OF HAPLO VERSUS HLA-MATCHED UNRELATED DONOR (UD) ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO HSCT) FOR PATIENTS OLDER THAN 55 YEARS
19. P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY
20. P828: NORMALIZATION OF HEMATOLOGIC AND HEALTH-RELATED QUALITY OF LIFE MARKERS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN AND BASELINE HEMOGLOBIN AT OR ABOVE 10 G/DL
21. P833: CATEGORIZING HEMATOLOGICAL RESPONSE TO PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS OF THE PHASE 3 PRINCE STUDY DATA
22. P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS
23. P1469: LONGITUDINAL SICKLE CELL DISEASE COHORT-STUDY: IN CHILDREN WITH SPLENIC SEQUESTRATION HISTORY OR HYPERSPLENISM, PARTIAL VS TOTAL SPLENECTOMY BEFORE STEM CELL TRANSPLANTATION PRESERVES SPLEEN FUNCTION
24. P824: HEMATOLOGIC FEATURES IN 102 FRENCH PATIENTS DIAGNOSED WITH GERMLINE MUTATIONS OF TELOMERES RELATED GENES AGED 15 YEARS OLD OR MORE
25. Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease
26. Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
27. In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
28. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes
29. Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
30. Interstitial Lung Diseases After Hematopoietic Stem Cell Transplantation: New Pattern of Lung Chronic Graft-Versus-Host Disease?
31. Bronchiectasis in Patients with Bronchiolitis Obliterans Syndrome After Hematopoietic Stem Cell Transplantation: A Distinct Phenotype?
32. Einsatz des oralen Komplementfaktor B-Inhibitors Iptacopan bei Patienten (pts) mit Paroxysmaler Nächtlicher Hämoglobinurie (PNH) mit anhaltende Hämolyse trotz einer Anti-C5 Therapie : langfristige Wirksamkeit und Sicherheit nach dem Absetzen von Eculizumab (ECU)
33. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey
34. P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED ADULT PATIENTS FROM THE DEFIFRANCE STUDY
35. Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation
36. Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy
37. Évaluation de deux scores pronostiques d’infection à VRS dans une cohorte multicentrique de patients allogreffés de cellules souches hématopoïétiques
38. Le syndrome de bronchiolite oblitérante avec bronchectasies : un phénotype distinct ?
39. S112: COMPARATIVE SCORE OF HOWELL-JOLLY BODIES IN SICKLE CELL DISEASE PATIENTS ACCORDING TO GENOTYPE, AGE, SPLENECTOMY OR STEM CELL TRANSPLANTATION HISTORY
40. Pneumopathies interstitielles diffuses au décours d’une allogreffe de cellules souches hématopoïétiques : nouvelle présentation de la réaction du greffon contre l’hôte chronique pulmonaire ?
41. Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT
42. Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
43. Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
44. Rechutes sévères de lymphome T cutané après traitement par ruxolitinib de la maladie du greffon contre l’hôte
45. Allogreffe dans les lymphomes T cutanés avancés (CUTALLO) : une étude prospective contrôlée multicentrique, appariée par score de propension
46. Traitement des lymphomes T cutanés par allogreffe de cellules souches hématopoïétiques
47. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
48. Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS
49. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
50. Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.